Carlos Peña, PhD – FDA

ix
Image of Carlos Peña from Working Group videocast March 4, 2015

Summary

Director, Division of Neurological and Physical Medicine Devices; Office of Device Evaluation; Center for Devices and Radiological Health; MetroHealth Medical Center - Food and Drug Administration
Ex Officio Member of Multi-Council Working Group

Dr. Peña is involved in all aspects of the safety and effectiveness review of neurostimulation, neurodiagnostic, neurosurgical, neurotherapeutic, and physical medicine devices. He also serves as a Principal Investigator on a FDA sponsored clinical study focused on the treatment of pediatric neurologic disorders.

 

Director, Division of Neurological and Physical Medicine Devices; Office of Device Evaluation; Center for Devices and Radiological Health; MetroHealth Medical Center – Food and Drug Administration
Ex Officio Member of Multi-Council Working Group 

Dr. Peña is involved in all aspects of the safety and effectiveness review of neurostimulation, neurodiagnostic, neurosurgical, neurotherapeutic, and physical medicine devices. He also serves as a Principal Investigator on a FDA sponsored clinical study focused on the treatment of pediatric neurologic disorders.

Web Information

Office of Device Evaluation Webpage: fda.gov/AboutFDA/CentersOffices/

Contact Information

Email:

Phone: 301-796-6610

Address: U.S. Food and Drug Administration
10903 New Hampshire Avenue
Silver Spring, MD 20993

Biosketch

Dr. Carlos Peña is Division Director for the Division of Neurological and Physical Medicine Devices, in the Office of Device Evaluation, Center for Devices and Radiological Health (CDRH), at the U.S. Food and Drug Administration (FDA).
Dr. Peña is involved in all aspects of the safety and effectiveness review of neurostimulation, neurodiagnostic, neurosurgical, neurotherapeutic, and physical medicine devices. He also serves as a Principal Investigator on a FDA sponsored clinical study focused on the treatment of pediatric neurologic disorders.

Prior to joining CDRH, Dr. Peña served on detail as Assistant Director for Emerging Technologies in the Office of Science and Technology Policy (OSTP), in the Executive Office of the President of the United States. His areas of expertise included science, technology, policy, analysis, and regulatory matters related to biology, neuroscience, biotechnology, emerging technologies, agriculture, and STEM education.

Before joining OSTP/FDA, Dr. Peña served at the National Institute of Neurological Disorders and Stroke, National Institutes of Health. He completed his neurosciences doctoral training at Case Western Reserve University in Cleveland, Ohio. He also attended the University of Connecticut for the Masters in Comparative Physiology, and the City College of New York, City University of New York, where he received a Bachelors specializing in Developmental Biology.

Skip to toolbar